Predicting mechanism of action of cellular perturbations with pathway activity signatures
暂无分享,去创建一个
Mario Medvedovic | Siva Sivaganesan | Yan Ren | Nicholas A. Clark | Wen Niu | Jacek Biesiada | Lixia Zhang | David R. Plas | M. Medvedovic | S. Sivaganesan | D. Plas | Yan Ren | Lixia Zhang | J. Biesiada | W. Niu
[1] Tony Hunter,et al. Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis , 2006, Molecular and Cellular Biology.
[2] Ralf Zimmer,et al. Bioconductor’s EnrichmentBrowser: seamless navigation through combined results of set- & network-based enrichment analysis , 2016, BMC Bioinformatics.
[3] Benjamin J. Raphael,et al. Network propagation: a universal amplifier of genetic associations , 2017, Nature Reviews Genetics.
[4] D. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[5] Pierre R. Bushel,et al. A Comparison of the TempO-Seq S1500+ Platform to RNA-Seq and Microarray Using Rat Liver Mode of Action Samples , 2018, Front. Genet..
[6] Yu Li,et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[7] J. Sáez-Rodríguez,et al. Perturbation-response genes reveal signaling footprints in cancer gene expression , 2016, Nature Communications.
[8] Atul J. Butte,et al. Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..
[9] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[10] J. Thomsen,et al. Mechanisms of estrogen action. , 2001, Physiological reviews.
[11] Sahin Albayrak,et al. Spectral Analysis of Signed Graphs for Clustering, Prediction and Visualization , 2010, SDM.
[12] Paul Workman,et al. Molecular pharmacology of phosphatidylinositol 3-kinase inhibition in human glioma , 2009, Cell cycle.
[13] Vasileios Stathias,et al. Connecting omics signatures of diseases, drugs, and mechanisms of actions with iLINCS , 2019, bioRxiv.
[14] Melvin E Andersen,et al. Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.
[15] Yoshihiro Yamanishi,et al. Elucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics , 2017, Scientific Reports.
[16] Robert J Kavlock,et al. Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.
[17] J. Olefsky,et al. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. , 2000, Molecular endocrinology.
[18] Jin Wang,et al. CePa: an R package for finding significant pathways weighted by multiple network centralities , 2013, Bioinform..
[19] Pankaj Agarwal,et al. Systematic evaluation of connectivity map for disease indications , 2014, Genome Medicine.
[20] Toren Finkel,et al. Signal transduction and human disease , 2003 .
[21] Alexander J. Smola,et al. Kernels and Regularization on Graphs , 2003, COLT.
[22] Andrea Califano,et al. PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens , 2017, Nature Communications.
[23] Elaine M. Faustman,et al. Implications for human health risk assessment , 2014 .
[24] Avi Ma'ayan,et al. L1000FWD: fireworks visualization of drug‐induced transcriptomic signatures , 2018, Bioinform..
[25] D. Fruman,et al. Context-Specific Function of S6K2 in Th Cell Differentiation , 2016, The Journal of Immunology.
[26] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[27] D. Fingar,et al. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. , 2012, The Biochemical journal.
[28] Cristina Mitrea,et al. Methods and approaches in the topology-based analysis of biological pathways , 2013, Front. Physiol..
[29] Daniel L Villeneuve,et al. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.
[30] Roberto Romero,et al. A Comparison of Gene Set Analysis Methods in Terms of Sensitivity, Prioritization and Specificity , 2013, PloS one.
[31] L. Wasserman,et al. Computing Bayes Factors by Combining Simulation and Asymptotic Approximations , 1997 .
[32] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[33] Angela N. Brooks,et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.
[34] Lori E. Dodd,et al. Partial AUC Estimation and Regression , 2003, Biometrics.
[35] Julio Saez-Rodriguez,et al. Footprint-based functional analysis of multiomic data , 2019, Current opinion in systems biology.
[36] William P Miller,et al. Activation of the Stress Response Kinase JNK (c-Jun N-terminal Kinase) Attenuates Insulin Action in Retina through a p70S6K1-dependent Mechanism* , 2016, The Journal of Biological Chemistry.
[37] Sandrine Dudoit,et al. More power via graph-structured tests for differential expression of gene networks , 2012, 1206.6980.
[38] Ben van Ommen,et al. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology , 2005, Expert review of proteomics.
[39] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[40] Jaques Reifman,et al. PathNet: a tool for pathway analysis using topological information , 2012, Source Code for Biology and Medicine.
[41] Y. Moreau,et al. Finding the targets of a drug by integration of gene expression data with a protein interaction network. , 2013, Molecular bioSystems.
[42] Susan K. Murphy,et al. Comprehensive Profiling of Amino Acid Response Uncovers Unique Methionine-Deprived Response Dependent on Intact Creatine Biosynthesis , 2015, PLoS genetics.
[43] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[44] M. Newton,et al. Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis , 2007, 0708.4350.
[45] Suimin Qiu,et al. Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer , 2009, Clinical Cancer Research.
[46] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[47] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[48] I. Gout,et al. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.
[49] Lovelace J. Luquette,et al. A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. , 2017, Cancer cell.